Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum

Kidney International

Volumn 61, Issue 2, 2002, Pages 534-541

  McCarthy, Ellen T ^a   Sharma, Mukut ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Albumin; Arachidonic acid; Cyclooxygenase inhibitor; Eicosanoids; Glomerular permeability; Proteinuria

Indexed keywords

ALBUMIN; ARACHIDONIC ACID; FUREGRELATE; ICOSANOID; INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCULATION; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; GLOMERULUS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEINURIA; RAT; SERUM;

EID: 0036151712     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00172.x     Document Type: Article

References (70)

1. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
2. Focal segmental glomerulosclerosis in children
3. The many masks of focal segmental glomerulosclerosis
4. Increasing incidence of focal segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study
5. Changing incidence of glomerular disease in adults
6. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
7. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis
8. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts
9. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmapheresis and cyclophosphamide
10. Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis
11. Plasma exchange for recurrent nephrotic syndrome following renal transplantation
12. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome
13. Treatment of the nephrotic syndrome with indomethacin
14. Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation
15. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation
16. Measurement of albumin reflection coefficient using isolated glomeruli
17. Altered glomerular eicosanoid biosynthesis in uranyl nitrate-induced acute renal failure
18. Prostaglandin and thromboxane synthesis by highly enriched rabbit proximal tubular cells in culture
19. 1 alpha formation by isolated human glomeruli
20. Eicosanoids and control of mesangial cell contraction
21. Angiotensin II and eicosanoids in the control of glomerular size in the rat and human
22. 2 on mRNA expression and secretion of collagens 1, 3, and 4 and fibronectin in cultured rat mesangial cells
23. 2 in cultured mesangial cells
24. Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells
25. Thromboxane stimulates synthesis of extracellular matrix proteins in vitro
26. Age-related differences and roles of endothelial citric oxide and prostanoids in angiotensin II responses of isolated, perfused mesenteric arteries and veins of rats
27. Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′pyridinylmethyl) benzofuran-2-carboxylate
28. 2 synthase inhibitors. 5-(3-pyridylmethyl) benzofuran-2-carboxylic acids
29. Effect of indomethacin on glomerular permeability in the nephrotic syndrome
30. Indomethacin and the nephrotic syndrome
31. Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study
32. Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: A controlled study
33. Treatment of severe nephrotic syndrome with meclofenamate: An uncontrolled pilot study
34. Refractory nephrotic syndrome in lupus nephritis: Favorable response to indomethacin therapy
35. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin
36. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy
37. Reduction of proteinuria by Indomethacin in patients with nephrotic syndrome
38. Exercise-induced proteinuria is attenuated by indomethacin
39. Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons
40. Effect of indomethacin on glomerular permselectivity and hemodynamics in nephrotoxic serum nephritis
41. Effects of indomethacin on glomerular hemodynamics in experimental diabetes
42. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril
43. Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: Will such treatments also help to improve renal function outcome?
44. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans
45. Acute effects of captopril and ibuprofen on proteinuria in patients with nephrosis
46. Eicosanoids in immune-mediated renal injury
47. Effects of nonsteroidal anti-inflammatory drugs on proteinuria
48. Prostaglandin synthesis in isolated rat kidney glomeruli
49. Prostaglandin synthesis in isolated glomeruli
50. Regulation and role of prostaglandin biosynthesis in cultured bovine glomerular endothelial cells
51. Prostaglandin and thromboxane synthesis by rat glomerular epithelial cells
52. Prostaglandin synthesis by rat glomerular mesangial cells in culture
53. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis
54. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis
55. 2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs
56. Indomethacin reduces proteinuria in passive Heymann nephritis in rats
57. A role for thromboxane in complement-mediated glomerular injury
58. Complement C5b-9 complex activates phospholipases in glomerular epithelial cells
59. Prostaglandin and thromboxane formation in glomeruli from rats with reduced renal mass
60. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation
61. Acquired essential fatty acid depletion in the remnant kidney: Amelioration with U-63557A
62. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney
63. A rat model of progressive chronic glomerular sclerosis: The role of thromboxane inhibition
64. High protein intake stimulates glomerular prostaglandin formation in remnant kidneys
65. Dietary protein intake modulates glomerular eicosanoid production in the rat
66. Indomethacin attenuates exercise-induced proteinuria in hypertensive miniature swine
67. Immune-mediated mesangial cell injury: Biosynthesis and function of prostanoids
68. Mesangial cell immune injury: Effects of thromboxane receptor antagonism
69. Mesangial cell immune injury: Synthesis, origin and role of eicosanoids
70. FSGS factor: Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma